Crescita Therapeutics Inc.
CRRTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $12 | $7 | $13 | $13 |
| - Cash | $9 | $9 | $8 | $11 |
| + Debt | $1 | $1 | $2 | $3 |
| Enterprise Value | $4 | -$1 | $7 | $5 |
| Revenue | $20 | $18 | $24 | $17 |
| % Growth | 11.7% | -25.5% | 40.3% | – |
| Gross Profit | $10 | $10 | $13 | $10 |
| % Margin | 49.1% | 59.1% | 56% | 59.7% |
| EBITDA | -$1 | -$0 | $2 | $1 |
| % Margin | -6.8% | -2.6% | 8.5% | 3.6% |
| Net Income | -$3 | -$2 | $1 | -$1 |
| % Margin | -14% | -11.3% | 3.7% | -6.6% |
| EPS Diluted | -0.14 | -0.098 | 0.041 | -0.053 |
| % Growth | -42.9% | -338.4% | 177.3% | – |
| Operating Cash Flow | $3 | $2 | -$1 | -$2 |
| Capital Expenditures | -$1 | -$0 | -$0 | -$0 |
| Free Cash Flow | $2 | $2 | -$1 | -$2 |